Table 2 Univariate analysis of YY1 expression and clinical pathological characteristics of patients
Clinical features | Number of cases 41 | YY1(low) (0-50% positive cells) 16 cases (39.0%) | YY1 (strong) (51%-100% positive cells) 25 cases (61.0%) | p |
|---|---|---|---|---|
Age (4-76) | 19.4 ± 15.6 | 24.4 ± 19.1 | 16.2 ± 12.0 | 0.099 |
Gender | Â | Â | Â | Â |
Male | 68.3 | 62.5 | 72.0 | 0.524 |
Chemonecrosis ≥ 90% | 36.6 | 37.5 | 36.0 | 0.923 |
Synchronous metastasis (%) | 34.1 | 25.0 | 40.0 | 0.323 |
Metachronous metastasis (%) * | 55.6 | 25.0 | 80.0 | 0.004 |
Mean time to metastasis (range 3-76 months) | 29.4 ± 19.2 | 37.6 ± 22.9 | 22.9 ± 13.1 | 0.047 |
Mortality | 46.3 | 18.8 | 64.0 | 0.005 |
Mean follow-up (range 3-95 months) | 47.0 ± 25.3 | 49.8 ± 27.5 | 45.2 ± 24.2 | 0.578 |